Lazard 二季报电话会重申 2027 年 Lazard CL 5 亿美元收入目标并恢复回购

Earnings Call Insights: Lazard (LAZ) Q2 2026
"Firm-wide adjusted net revenue was $786 million for the second quarter and $1.5 billion for the first half of the year." (CEO & Chairman Peter Orszag)
"In the first half of this year, Financial Advisory achieved its strongest announced lead table position since 2014." (CEO & Chairman Orszag)
"Asset Management delivered its best first half net inflows in nearly 20 years and reached its highest reported AUM level ever." (CEO & Chairman Orszag)
"With our acquisition of Campbell Lutyens, we will establish a third business that will be the leader in global private capital advisory." (CEO & Chairman Orszag)
"Financial Advisory adjusted net revenue was $445 million for the second quarter and $801 million for the first half of 2026." (Chief Financial Officer Tracy Farr)
"Our quantitative equity business, the Lazard Advantage platform has more than doubled to $50 billion in assets under management in the past year." (CFO Farr)
"Our adjusted effective tax rate for the second quarter was 69.7%...anomalous and associated with the catch-up adjustment with divesting of equity." (CFO Farr)
"We declared a quarterly dividend of $0.50 per share." (CFO Farr)
"We are now exiting the transitional period...and moving toward a phase in which the investments we have already made shift to a meaningful tailwind for future growth." (CEO & Chairman Orszag)
"As we look ahead, firm-wide total revenue in the second half of the year is usually stronger than the first half...This year, our current projections suggest that pattern will be somewhat more pronounced." (CFO Farr)
"We remain on track to deliver positive net flows for the year." (CEO & Chairman Orszag)
"We expect this acquisition to be accretive to earnings in 2027 and thereafter." (CEO & Chairman Orszag)
Compared with last quarter’s framing that "several transactions move[d] to later in the year," management in Q2 said, "there was no exceptional pull forward" and emphasized "increasing momentum across the business." (CEO & Chairman Orszag)
"Firm-wide adjusted net revenue was $786 million for the second quarter" and Asset Management "adjusted net revenue was $331 million for the second quarter." (CEO & Chairman Orszag; CFO Farr)
Asset Management results included "management fees of $310 million" and "market appreciation of $27 billion" alongside "outflows of $1.6 billion" during the quarter. (CFO Farr)
"As of June 30, we reported an AUM of $285 billion" and "we delivered net inflows of $7.4 billion in the first half of the year." (CFO Farr)
On expenses, "adjusted noncompensation expense was $172 million" and "adjusted compensation expense was $550 million...resulting in a compensation ratio of 69.9%." (CFO Farr)
Capital return included "$103 million to shareholders" and buybacks restarting: "we are pleased to restart our share buybacks with a current repurchase authorization of just over $250 million." (CFO Farr)
"Why we're seeing that divergence" in strategic vs. sponsor M&A and the outlook for sponsors; CEO Orszag: "the core challenge...involves valuations" and described "building pressure" for distributions, adding, "we see [secondaries] as quite robust." (Gabriel Angelini, BofA Securities; CEO Orszag)
Asset Management changes and KPIs; CEO Hogbin: "appoint a Chief Investment Officer for the first time" and said "68% of AUM...outperforming their stated benchmarks over 5 years," while pointing to flows as "what's happening to our flows." (Angelini, BofA Securities; CEO Hogbin)
Advisory second-half seasonality magnitude; CFO Farr: "that first half versus second half trend might be more pronounced this year" given "the pace of that pipeline build." (Brennan Hawken, BMO; CFO Farr)
MD headcount and ramp; CEO Orszag: "We will be at least at 248...by the end of the first quarter of 2027" and said 2024 was a "headwind" turning into a "quite significant tailwind" in 2027. (Hawken, BMO; CEO Orszag)
Asset Management flow puts/takes and comp ratio sensitivity; CEO Hogbin: "institutional...is lumpier" but "very confident" given pipeline, while CFO Farr said comp ratio improvement is "indexed to FA performance in the second half of the year." (Michael Brown, UBS; CEO Hogbin; CFO Farr)
AI and cost trajectory; CEO Orszag: "committed to not locking into a single model" and said "our AI spend and token cost is still quite modest," while CFO Farr described an "in-depth review" to create "structural change that is sticky." (James Yaro, Goldman; Connell Schmitz, Morgan Stanley; CEO Orszag; CFO Farr)
Long-term comp trajectory and non-M&A momentum; CEO Orszag said the comp ratio declines via "a time effect," "operating leverage," and "direct efficiency effect," and added, "we still believe that the Lazard CL combination will produce $500 million in revenue in 2027." (Steven Chubak, Wolfe; CEO Orszag)
Large-deal acceleration and mid-market pickup; CEO Orszag said uplift reflects "partly market, partly a leadership initiative" and noted forward indicators are strong "despite the fact that private equity M&A has not yet kind of fully reawakened." (Devin Ryan, Citizens JMP; Alexander Bond, KBW; CEO Orszag)
Non-comp guidance and travel/AI; CFO Farr: "that guidance still holds" for "mid- to high single-digit" growth, adding AI costs are "not yet material" and higher client convening is "not something we're trying to dial back." (Bond, KBW; CFO Farr)
Slightly negative-to-skeptical on sponsor M&A and expense/comp sensitivity, with questions pressing on "divergence" in sponsor activity, "magnitude" of 2H advisory seasonality, and comp "visibility". (Analysts)
Slightly positive in prepared remarks and more explanatory in Q&A, emphasizing confidence signals like "reinforce our confidence" and "very encouraging," while also using caveats such as "progress...is not linear" and comp outcomes depend on "several factors...still evolving." (Management)
Versus last quarter’s repeated focus on deal slippage and the Campbell Lutyens announcement, this quarter’s tone leaned toward execution detail (MD ramp, AI rollout, buyback restart) and included a notable defensive clarification: "there was no exceptional pull forward." (CEO & Chairman Orszag)
Q2 highlighted a tax-driven earnings headwind: "adjusted effective tax rate...was 69.7%...anomalous" versus Q1 noting "discrete tax benefits" and reiterating a full-year rate in the "high 20s percent range" on a GAAP basis. (CFO Farr)
Q2 restarted capital returns: "restart our share buybacks" after Q1’s pause amid the Campbell Lutyens deal process. (CFO Farr)
Q2 provided deeper advisory leading indicators (e.g., "up over 100% for deals above $5 billion" and 2027 pipeline "more than twice" last year’s level at the same time) compared with Q1’s disclosure that clearances above $5 billion were "up 50% year-over-year." (CEO & Chairman Orszag)
"Private equity M&A has remained subdued" and the recovery depends on "valuations" and the rate environment, with management noting, "we will await those words converting into action." (CEO & Chairman Orszag)
Expense visibility remained a management theme, with compensation ratio levers described as "still evolving" and non-comp impacted by transaction-related items and higher client activity. (CFO Farr)
Integration risk was acknowledged implicitly through the focus on execution: "Integration planning is well underway for the Campbell Lutyens acquisition." (CEO & Chairman Orszag)
Lazard management framed Q2 around tangible Lazard 2030 execution: stronger firmwide adjusted net revenue, record reported AUM, and detailed evidence that advisory productivity is emerging from a self-described “J-curve” after large MD turnover. The company reiterated that Campbell Lutyens is expected to be earnings accretive in 2027 and reaffirmed the $500 million combined 2027 revenue goal for Lazard CL, while highlighting that second-half revenue is projected to be more seasonally back-end loaded than usual and that compensation leverage depends on Financial Advisory’s second-half conversion. The quarter also included an unusually high adjusted effective tax rate described as “anomalous,” alongside a restart of share repurchases with authorization “just over $250 million.”